Successful Treatment of Severe Acute Pancreatitis-Related ARDS With Systemic Infusion of Neutrophil Elastase Inhibitor (Sivelestat Sodium)

Suizo
doi 10.2958/suizo.20.477
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Pancreas Society

Related search

Effect of Neutrophil Elastase Inhibitor (Sivelestat Sodium) in the Treatment of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS): A Systematic Review and Meta-Analysis

Internal Medicine
Internal MedicineMedicine
2010English

Clinical Utility of the Neutrophil Elastase Inhibitor Sivelestat for the Treatment of Acute Respiratory Distress Syndrome

Therapeutics and Clinical Risk Management
2014English

Sivelestat (Selective Neutrophil Elastase Inhibitor) Improves the Mortality Rate of Sepsis Associated With Both Acute Respiratory Distress Syndrome and Disseminated Intravascular Coagulation Patients

Shock
Critical CareEmergency MedicineIntensive Care Medicine
2010English

A Case of Severe Acute Pancreatitis Associated With a Systemic Cytomegalovirus Infection

Suizo
2010English

Human Neutrophil Elastase Degrades Inter-.Alpha.-Trypsin Inhibitor to Liberate Urinary Trypsin Inhibitor Related Proteins.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
1998English

Oxidized Mucus Proteinase Inhibitor: A Fairly Potent Neutrophil Elastase Inhibitor

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1994English

Management of Severe Acute Pancreatitis

British Medical Journal
Medicine
2019English

Phase II Study of a Neutrophil Elastase Inhibitor (AZD9668) in Patients With Bronchiectasis

Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Treatment With DNases Rescues Hidden Neutrophil Elastase From Aggregated NETs

Journal of Leukocyte Biology
AllergyImmunologyCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy